Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SC01009 in Idiopathic Pulmonary Fibrosis
NCT07131150Phase 2Not yet recruiting
- Sponsor
- Ruijin Hospital
- Start
- Aug 2025
- Primary completion
- Jul 2028
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of SC01009 in idiopathic pulmonary fibrosis (IPF), sponsored by Ruijin Hospital. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
SC01009
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT07131150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07131150.